Drawing for OSNA

USPTO serial 88022705

OSNA

Reviewed by CopyMark Law Group

Reg. 6868542Status 700Registered
Filing date
Status date
Registration date
Oct 11, 2022
Examiner
REEVES, APRIL ELIZABETH
Law office
TMO LAW OFFICE 124

What this means

Status 700 means the trademark is registered and active on the Principal Register. You have nationwide rights for the listed goods and services and may use ®. Section 8 maintenance is due between years five and six. Calendar Section 8 between years five and six, and consider trademark monitoring.

Status 700: Status 700 means the trademark is registered and active on the Principal Register. You have nationwide rights for the listed goods and services and may use ®. Section 8 maintenance is due between years five and six.

Need help with OSNA?

If you own this trademark, we can monitor new filings and help with USPTO deadlines. If you do not, we can file a new U.S. application.

Current trademark owner
Monitor this mark, or talk with CopyMark about this registration.
Not the owner?
File a new U.S. trademark application, or speak with our attorneys.

Owner

Attorney of record

The USPTO lists this attorney as the applicant's representative for correspondence on this application.

Virginia Wolk Marino

Virginia Wolk Marino CROWELL & MORINGP.O. BOX 10395CHICAGO, IL 60610UNITED STATES

Goods and services

ClassDescriptionStatusFirst use
005Diagnostic reagents and diagnostic preparations for medical or veterinary purposes; chemical reagents and chemical preparations for medical or veterinary purposes; chemical reagents and chemical preparations for medical or pharmaceutical purposes, namely, reagents for detecting metastasis of cancer; testing reagents and preparations for medical or veterinary purposes; pharmaceutical preparations for in vitro diagnosis; reagents for medical use, namely, reagents for genetic test; reagents for medical use, namely, reagents for amplification and detection of genes; reagents for medical use, namely, lymph node solubilizing reagents; reagents for medical use, namely, reagents for protein test; reagents for medical use, namely, reagents for cancer recurrence prediction test; reagents for medical use, namely, reagents for anticancer drug sensitivity prediction test; diluents for medical or veterinary purposes; diluents for medical or clinical diagnostic use; diluents for genetic test for medical or clinical diagnostic use; reference control materials for medical use; quality control standard solutions and quality control reagents for testing and calibrating medical apparatus and reagentsACTIVE—
009Gene amplification or detection device for scientific or research use, namely, for detecting metastasis of cancer; laboratory apparatus and instruments, namely, for genetic testing for scientific and research purposes; measuring or testing machines and instruments for analyzing blood, body fluid, tissue or other biological samples not for medical purposesACTIVE—
010Diagnostic apparatus and instruments for medical purposes, namely, for testing DNA or RNA; diagnostic or measuring apparatus and instruments for medical purposes in the nature of genetic testing apparatus and instruments, namely, gene amplification detector, cancer metastasis analyzer, cell cycle analyzer, cancer recurrence prediction testing apparatus and instruments, anticancer drug sensitivity prediction testing apparatus and instruments, sample transfer apparatus, sample container transfer apparatus, and sample rack transfer apparatus; measuring apparatus and instruments for medical purposes for analyzing genes; pipettes for medical purposes; containers for samples for in vitro diagnosis; sampling bottles for medical purposesACTIVE—
042Medical or scientific research on cancer diagnosis; medical research; providing information relating to medical research; testing, examination or research of reagents and other medicines; testing, examination or research of medical apparatus and instruments and other machines; technological advice relating to medical apparatus and instruments, laboratory apparatus and instruments, measuring or testing machines and instruments, testing apparatus and instruments, computers and other machines; rental of gene amplification or detection device for scientific or research use; rental of laboratory apparatus and instruments; rental of measuring or testing machines and instruments for medical or scientific research; all of the foregoing for use with medical and scientific research in the field of cancer diagnosisACTIVE—
044Clinical genetic testing for detecting metastasis of cancer for diagnostic or treatment purposes; clinical testing of genes in lymph node for medical purposes; providing information relating clinical testing, namely, genetic testing; medical analysis and evaluation of clinical laboratory tests results for diagnosis of cancer metastasis or other diseases; providing medical information in the field of genetic testing; rental of medical apparatus and instrumentsACTIVE—

Related trademarks

CopyMark links this record to cited §2(d) serials, the owner's other marks, Nice classes, similar mark names, and recently changed USPTO applications.

Prosecution history

DateCodeEventWhat it means
Apr 4, 2023NURCNOTICE OF UPDATED REGISTRATION CONFIRMATION EMAILED—
Mar 2, 2023COC.CORRECTION UNDER SECTION 7 - PROCESSED—
Feb 3, 2023XXXXPOST REGISTRATION ACTION CORRECTION—
Feb 3, 2023WDRLOTQR WITHDRAWAL FROM PUBLICATION—
Dec 20, 2022APRECASE ASSIGNED TO POST REGISTRATION PARALEGAL—
Dec 20, 2022A7OKAMENDMENT UNDER SECTION 7 - PROCESSED—
Oct 28, 2022APRECASE ASSIGNED TO POST REGISTRATION PARALEGAL—
Oct 11, 2022NRCCNOTICE OF REGISTRATION CONFIRMATION EMAILED—
Oct 11, 2022R.PRREGISTERED-PRINCIPAL REGISTERYour trademark is registered on the Principal Register — the strongest form of federal trademark protection. You may use the ® symbol for the covered goods and services. Maintenance filings (Section 8 and renewals) are required to keep the registration alive.
Oct 8, 2022CHPNPOST PUBLICATION AMENDMENT – NOT ENTERED—
Oct 4, 2022APETASSIGNED TO PETITION STAFF—
Sep 19, 2022EPPATEAS POST PUBLICATION AMENDMENT RECEIVED—
Sep 8, 2022FIXDELECTRONIC RECORD REVIEW COMPLETE—
Aug 12, 2022ERRRON HOLD - ELECTRONIC RECORD REVIEW REQUIRED—
Aug 5, 2022ERRRON HOLD - ELECTRONIC RECORD REVIEW REQUIRED—
Aug 3, 2022TCCATEAS CHANGE OF CORRESPONDENCE RECEIVED—
Aug 3, 2022EWAFTEAS WITHDRAWAL OF ATTORNEY RECEIVED-FIRM RETAINS—
Aug 3, 2022ARAAATTORNEY/DOM.REP.REVOKED AND/OR APPOINTEDThis event means the applicant filed a response to a USPTO Office Action — typically arguments, amendments, or evidence addressing the examiner's objections. The USPTO will review the response and either allow the mark to proceed or issue another action.
Aug 3, 2022REAPTEAS REVOKE/APP/CHANGE ADDR OF ATTY/DOM REP RECEIVED—
Aug 1, 2022DP1B1(B) BASIS DELETED; PROCEED TO REGISTRATION—
Jul 28, 2022IUCNNOTICE OF ALLOWANCE CANCELLED—
Jul 28, 2022D1BRTEAS DELETE 1(B) BASIS RECEIVED—
Feb 17, 2022EXRANOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED—
Feb 16, 2022EX5GSOU EXTENSION 5 GRANTED—
Feb 16, 2022AITUCASE ASSIGNED TO INTENT TO USE PARALEGAL—
Feb 9, 2022EXT5SOU EXTENSION 5 FILED—
Feb 9, 2022EEXTSOU TEAS EXTENSION RECEIVEDThe applicant requested more time to file a Statement of Use before the Notice of Allowance deadline. Each extension typically adds six months. A limited number of extensions are available for intent-to-use applications not yet in use.
Aug 21, 2021EXRANOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED—
Aug 19, 2021EX4GSOU EXTENSION 4 GRANTED—
Aug 19, 2021EXT4SOU EXTENSION 4 FILED—
Aug 19, 2021EEXTSOU TEAS EXTENSION RECEIVEDThe applicant requested more time to file a Statement of Use before the Notice of Allowance deadline. Each extension typically adds six months. A limited number of extensions are available for intent-to-use applications not yet in use.
Feb 18, 2021EXRANOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED—
Feb 16, 2021EX3GSOU EXTENSION 3 GRANTED—
Feb 16, 2021EXT3SOU EXTENSION 3 FILED—
Feb 16, 2021EEXTSOU TEAS EXTENSION RECEIVEDThe applicant requested more time to file a Statement of Use before the Notice of Allowance deadline. Each extension typically adds six months. A limited number of extensions are available for intent-to-use applications not yet in use.
Aug 28, 2020EXRANOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED—
Aug 26, 2020EX2GSOU EXTENSION 2 GRANTED—
Aug 26, 2020EXT2SOU EXTENSION 2 FILED—
Aug 26, 2020EEXTSOU TEAS EXTENSION RECEIVEDThe applicant requested more time to file a Statement of Use before the Notice of Allowance deadline. Each extension typically adds six months. A limited number of extensions are available for intent-to-use applications not yet in use.
Jan 28, 2020EXRANOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED—
Jan 24, 2020EX1GSOU EXTENSION 1 GRANTED—
Jan 24, 2020EXT1SOU EXTENSION 1 FILED—
Jan 24, 2020EEXTSOU TEAS EXTENSION RECEIVEDThe applicant requested more time to file a Statement of Use before the Notice of Allowance deadline. Each extension typically adds six months. A limited number of extensions are available for intent-to-use applications not yet in use.
Oct 8, 2019CHPBPOST PUBLICATION AMENDMENT - ENTERED—
Sep 25, 2019EWAFTEAS WITHDRAWAL OF ATTORNEY RECEIVED-FIRM RETAINS—
Sep 10, 2019NOAMNOA E-MAILED - SOU REQUIRED FROM APPLICANTA Notice of Allowance means your intent-to-use application cleared examination and opposition but is not registered yet. You must file a Statement of Use showing the mark in commerce, or request an extension, before the deadline — usually six months from the notice date.
Jul 16, 2019NPUBOFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED—
Jul 16, 2019PUBOPUBLISHED FOR OPPOSITIONYour mark was published in the USPTO Official Gazette for a 30-day opposition window. During that period, third parties who believe they would be harmed can file an opposition. If no opposition is filed, prosecution usually continues toward registration or a Notice of Allowance.
Jun 26, 2019NONPNOTIFICATION OF NOTICE OF PUBLICATION E-MAILED—
Jun 12, 2019PREVLAW OFFICE PUBLICATION REVIEW COMPLETED—
Jun 10, 2019CNSAAPPROVED FOR PUB - PRINCIPAL REGISTER—
Jun 10, 2019TEMETEAS/EMAIL CORRESPONDENCE ENTERED—
Jun 10, 2019CRFACORRESPONDENCE RECEIVED IN LAW OFFICE—
Jun 6, 2019ERFRTEAS REQUEST FOR RECONSIDERATION RECEIVED—
May 8, 2019GNFNNOTIFICATION OF FINAL REFUSAL EMAILED—
May 8, 2019GNFRFINAL REFUSAL E-MAILEDA final Office Action (final refusal) means the examining attorney is maintaining at least one refusal and your options are narrower. You can file a response addressing the refusal, appeal to the Trademark Trial and Appeal Board, or let the application abandon.
May 8, 2019CNFRFINAL REFUSAL WRITTENA final Office Action (final refusal) means the examining attorney is maintaining at least one refusal and your options are narrower. You can file a response addressing the refusal, appeal to the Trademark Trial and Appeal Board, or let the application abandon.
Apr 9, 2019TEMETEAS/EMAIL CORRESPONDENCE ENTERED—
Apr 9, 2019CRFACORRESPONDENCE RECEIVED IN LAW OFFICE—
Apr 8, 2019ALIEASSIGNED TO LIE—
Apr 3, 2019TROATEAS RESPONSE TO OFFICE ACTION RECEIVEDThis event means the applicant filed a response to a USPTO Office Action — typically arguments, amendments, or evidence addressing the examiner's objections. The USPTO will review the response and either allow the mark to proceed or issue another action.
Oct 9, 2018GNRNNOTIFICATION OF NON-FINAL ACTION E-MAILEDA non-final Office Action means the USPTO examining attorney has raised at least one issue with your trademark application but has not made a final decision. You usually have three months to respond with arguments, amendments, or evidence. Missing the deadline can abandon the application.
Oct 9, 2018GNRTNON-FINAL ACTION E-MAILEDA non-final Office Action means the USPTO examining attorney has raised at least one issue with your trademark application but has not made a final decision. You usually have three months to respond with arguments, amendments, or evidence. Missing the deadline can abandon the application.
Oct 9, 2018CNRTNON-FINAL ACTION WRITTENA non-final Office Action means the USPTO examining attorney has raised at least one issue with your trademark application but has not made a final decision. You usually have three months to respond with arguments, amendments, or evidence. Missing the deadline can abandon the application.
Sep 25, 2018DOCKASSIGNED TO EXAMINER—
Jul 10, 2018MDSCNOTICE OF DESIGN SEARCH CODE E-MAILED—
Jul 7, 2018NWOSNEW APPLICATION OFFICE SUPPLIED DATA ENTERED—
Jul 5, 2018NWAPNEW APPLICATION ENTERED—

Frequently asked questions

Related guidance